APO Research
Talk to an analyst

APO RESEARCH · REPORT

Post herpetic Neuralgia Treatment

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Selected research

Market Analysis & Forecast

Global Post herpetic Neuralgia Treatment Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchPost herpetic Neuralgia Treatment Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Post herpetic Neuralgia Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Post herpetic Neuralgia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Post herpetic Neuralgia Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Post herpetic Neuralgia Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.

Read the full market overview

In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

Report Includes

This report presents an overview of global market for Post herpetic Neuralgia Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Post herpetic Neuralgia Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Post herpetic Neuralgia Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Post herpetic Neuralgia Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Post herpetic Neuralgia Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Post herpetic Neuralgia Treatment revenue, projected growth trends, production technology, application and end-user industry.

Post herpetic Neuralgia Treatment Segment by Company

Pfizer

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

Teva

Mylan

Hengrui Medicine

Post herpetic Neuralgia Treatment Segment by Type

Anticonvulsants

Skin Patch

Other

Post herpetic Neuralgia Treatment Segment by Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Post herpetic Neuralgia Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post herpetic Neuralgia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Post herpetic Neuralgia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post herpetic Neuralgia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Post herpetic Neuralgia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post herpetic Neuralgia Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anticonvulsants Major Player Table 3. Skin Patch Major Player Table 4. Other Major Player Table 5. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Distribution Channel (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Player Table 7. Online Pharmacies Major Player Table 8. Retail Pharmacies Major Player Table 9. Post herpetic Neuralgia Treatment Industry Trends Table 10. Post herpetic Neuralgia Treatment Industry Drivers Table 11. Post herpetic Neuralgia Treatment Industry Opportunities and Challenges Table 12. Post herpetic Neuralgia Treatment Industry Restraints Table 13. Global Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Post herpetic Neuralgia Treatment Market Share by Region (2021-2026) Table 16. Global Post herpetic Neuralgia Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Post herpetic Neuralgia Treatment Market Share by Region (2027-2032) Table 18. Global Post herpetic Neuralgia Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Post herpetic Neuralgia Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Post herpetic Neuralgia Treatment Key Players Headquarters & Area Served Table 22. Global Post herpetic Neuralgia Treatment Players, Product Type & Application Table 23. Global Post herpetic Neuralgia Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Post herpetic Neuralgia Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Post herpetic Neuralgia Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 33. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 34. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2021-2026) Table 35. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2027-2032) Table 36. Pfizer Company Information Table 37. Pfizer Business Overview Table 38. Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Pfizer Post herpetic Neuralgia Treatment Product Portfolio Table 40. Pfizer Recent Development Table 41. Arbor Pharma Company Information Table 42. Arbor Pharma Business Overview Table 43. Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 45. Arbor Pharma Recent Development Table 46. Assertio Therapeutics Company Information Table 47. Assertio Therapeutics Business Overview Table 48. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio Table 50. Assertio Therapeutics Recent Development Table 51. Endo Pharma Company Information Table 52. Endo Pharma Business Overview Table 53. Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 55. Endo Pharma Recent Development Table 56. Teikoku Pharma Company Information Table 57. Teikoku Pharma Business Overview Table 58. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 60. Teikoku Pharma Recent Development Table 61. Teva Company Information Table 62. Teva Business Overview Table 63. Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Teva Post herpetic Neuralgia Treatment Product Portfolio Table 65. Teva Recent Development Table 66. Mylan Company Information Table 67. Mylan Business Overview Table 68. Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Mylan Post herpetic Neuralgia Treatment Product Portfolio Table 70. Mylan Recent Development Table 71. Hengrui Medicine Company Information Table 72. Hengrui Medicine Business Overview Table 73. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio Table 75. Hengrui Medicine Recent Development Table 76. North America Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 79. North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 80. North America Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Post herpetic Neuralgia Treatment Revenue by Country (2021-2026) & (US$ Million) Table 82. North America Post herpetic Neuralgia Treatment Revenue by Country (US$ Million) & (2027-2032) Table 83. Europe Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 86. Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 87. Europe Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Post herpetic Neuralgia Treatment Revenue by Country (2021-2026) & (US$ Million) Table 89. Europe Post herpetic Neuralgia Treatment Revenue by Country (US$ Million) & (2027-2032) Table 90. China Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 91. China Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 92. China Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 93. China Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 94. Asia Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 95. Asia Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 96. Asia Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 97. Asia Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 98. Asia Post herpetic Neuralgia Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Post herpetic Neuralgia Treatment Revenue by Region (US$ Million) & (2021-2026) Table 100. Asia Post herpetic Neuralgia Treatment Revenue by Region (US$ Million) & (2027-2032) Table 101. SAMEA Post herpetic Neuralgia Treatment Revenue by Type (2021-2026) & (US$ Million) Table 102. SAMEA Post herpetic Neuralgia Treatment Revenue by Type (2027-2032) & (US$ Million) Table 103. SAMEA Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026) & (US$ Million) Table 104. SAMEA Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032) & (US$ Million) Table 105. SAMEA Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. SAMEA Post herpetic Neuralgia Treatment Revenue by Country (2021-2026) & (US$ Million) Table 107. SAMEA Post herpetic Neuralgia Treatment Revenue by Country (US$ Million) & (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Post herpetic Neuralgia Treatment Image Figure 2. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Post herpetic Neuralgia Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anticonvulsants Image Figure 5. Skin Patch Image Figure 6. Other Image Figure 7. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Distribution Channel (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Post herpetic Neuralgia Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Post herpetic Neuralgia Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Post herpetic Neuralgia Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Post herpetic Neuralgia Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Post herpetic Neuralgia Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Post herpetic Neuralgia Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Post herpetic Neuralgia Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2021 VS 2025 VS 2032) Figure 22. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2021-2032) Figure 23. North America Post herpetic Neuralgia Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032) Figure 25. North America Post herpetic Neuralgia Treatment Revenue Share by Application (2021-2032) Figure 26. North America Post herpetic Neuralgia Treatment Revenue Share by Country (2021-2032) Figure 27. United States Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Post herpetic Neuralgia Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Post herpetic Neuralgia Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Post herpetic Neuralgia Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Post herpetic Neuralgia Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032) Figure 44. China Post herpetic Neuralgia Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Post herpetic Neuralgia Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Post herpetic Neuralgia Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Post herpetic Neuralgia Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Post herpetic Neuralgia Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Post herpetic Neuralgia Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Post herpetic Neuralgia Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Post herpetic Neuralgia Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Anticonvulsants
  • Skin Patch
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Pfizer
  • Arbor Pharma
  • Assertio Therapeutics
  • Endo Pharma
  • Teikoku Pharma
  • Teva
  • Mylan
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Post herpetic Neuralgia Treatment Market by Type
  3. 1.2.1 Global Post herpetic Neuralgia Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anticonvulsants
  5. 1.2.3 Skin Patch
  6. 1.2.4 Other
  7. 1.3 Post herpetic Neuralgia Treatment Market by Distribution Channel
  8. 1.3.1 Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Post herpetic Neuralgia Treatment Market Dynamics
  1. 2.1 Post herpetic Neuralgia Treatment Industry Trends
  2. 2.2 Post herpetic Neuralgia Treatment Industry Drivers
  3. 2.3 Post herpetic Neuralgia Treatment Industry Opportunities and Challenges
  4. 2.4 Post herpetic Neuralgia Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Post herpetic Neuralgia Treatment Market Perspective (2021-2032)
  2. 3.2 Global Post herpetic Neuralgia Treatment Growth Trends by Region
  3. 3.2.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Post herpetic Neuralgia Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Post herpetic Neuralgia Treatment Revenue by Players
  2. 4.1.1 Global Post herpetic Neuralgia Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Post herpetic Neuralgia Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Post herpetic Neuralgia Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Post herpetic Neuralgia Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Post herpetic Neuralgia Treatment Players, Product Type & Application
  8. 4.5 Global Post herpetic Neuralgia Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Post herpetic Neuralgia Treatment Market CR5 and HHI
  11. 4.6.3 2025 Post herpetic Neuralgia Treatment Tier 1, Tier 2, and Tier 3
5 Post herpetic Neuralgia Treatment Market Size by Type
  1. 5.1 Global Post herpetic Neuralgia Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2021-2032)
6 Post herpetic Neuralgia Treatment Market Size by Application
  1. 6.1 Global Post herpetic Neuralgia Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Post herpetic Neuralgia Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Post herpetic Neuralgia Treatment Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Arbor Pharma
  8. 7.2.1 Arbor Pharma Company Information
  9. 7.2.2 Arbor Pharma Business Overview
  10. 7.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio
  12. 7.2.5 Arbor Pharma Recent Developments
  13. 7.3 Assertio Therapeutics
  14. 7.3.1 Assertio Therapeutics Company Information
  15. 7.3.2 Assertio Therapeutics Business Overview
  16. 7.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio
  18. 7.3.5 Assertio Therapeutics Recent Developments
  19. 7.4 Endo Pharma
  20. 7.4.1 Endo Pharma Company Information
  21. 7.4.2 Endo Pharma Business Overview
  22. 7.4.3 Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio
  24. 7.4.5 Endo Pharma Recent Developments
  25. 7.5 Teikoku Pharma
  26. 7.5.1 Teikoku Pharma Company Information
  27. 7.5.2 Teikoku Pharma Business Overview
  28. 7.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio
  30. 7.5.5 Teikoku Pharma Recent Developments
  31. 7.6 Teva
  32. 7.6.1 Teva Company Information
  33. 7.6.2 Teva Business Overview
  34. 7.6.3 Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Teva Post herpetic Neuralgia Treatment Product Portfolio
  36. 7.6.5 Teva Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Post herpetic Neuralgia Treatment Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Hengrui Medicine
  44. 7.8.1 Hengrui Medicine Company Information
  45. 7.8.2 Hengrui Medicine Business Overview
  46. 7.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio
  48. 7.8.5 Hengrui Medicine Recent Developments
8 North America
  1. 8.1 North America Post herpetic Neuralgia Treatment Revenue (2021-2032)
  2. 8.2 North America Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Post herpetic Neuralgia Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Post herpetic Neuralgia Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2032)
  7. 8.4.1 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026)
  8. 8.4.2 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032)
  9. 8.5 North America Post herpetic Neuralgia Treatment Revenue Share by Distribution Channel (2021-2032)
  10. 8.6 North America Post herpetic Neuralgia Treatment Revenue by Country
  11. 8.6.1 North America Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Post herpetic Neuralgia Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Post herpetic Neuralgia Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Post herpetic Neuralgia Treatment Revenue (2021-2032)
  2. 9.2 Europe Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Post herpetic Neuralgia Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Post herpetic Neuralgia Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2032)
  7. 9.4.1 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026)
  8. 9.4.2 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032)
  9. 9.5 Europe Post herpetic Neuralgia Treatment Revenue Share by Distribution Channel (2021-2032)
  10. 9.6 Europe Post herpetic Neuralgia Treatment Revenue by Country
  11. 9.6.1 Europe Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Post herpetic Neuralgia Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Post herpetic Neuralgia Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Post herpetic Neuralgia Treatment Revenue (2021-2032)
  2. 10.2 China Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Post herpetic Neuralgia Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Post herpetic Neuralgia Treatment Revenue by Type (2027-2032)
  5. 10.3 China Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2032)
  7. 10.4.1 China Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026)
  8. 10.4.2 China Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032)
  9. 10.5 China Post herpetic Neuralgia Treatment Revenue Share by Distribution Channel (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Post herpetic Neuralgia Treatment Revenue (2021-2032)
  2. 11.2 Asia Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Post herpetic Neuralgia Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Post herpetic Neuralgia Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2032)
  7. 11.4.1 Asia Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026)
  8. 11.4.2 Asia Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032)
  9. 11.5 Asia Post herpetic Neuralgia Treatment Revenue Share by Distribution Channel (2021-2032)
  10. 11.6 Asia Post herpetic Neuralgia Treatment Revenue by Country
  11. 11.6.1 Asia Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Post herpetic Neuralgia Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Post herpetic Neuralgia Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Post herpetic Neuralgia Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Post herpetic Neuralgia Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Post herpetic Neuralgia Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Post herpetic Neuralgia Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Post herpetic Neuralgia Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2032)
  7. 12.4.1 SAMEA Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2021-2026)
  8. 12.4.2 SAMEA Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2027-2032)
  9. 12.5 SAMEA Post herpetic Neuralgia Treatment Revenue Share by Distribution Channel (2021-2032)
  10. 12.6 SAMEA Post herpetic Neuralgia Treatment Revenue by Country
  11. 12.6.1 SAMEA Post herpetic Neuralgia Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Post herpetic Neuralgia Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Post herpetic Neuralgia Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst